Why the study?
Do rotavirus vaccines prevent severe gastroenteritis in US children?
Do rotavirus vaccines prevent severe gastroenteritis in US children?
Rotavirus vaccines have been highly effective in reducing severe gastroenteritis in the US, providing both direct protection to vaccinated children and indirect herd immunity to older, unvaccinated groups.
Answers are grounded in this paper and cite their sources.
Sustains US rotavirus vaccination programs; extends herd-immunity evidence but leaves open durability and strain-shift monitoring.
Prior to the introduction of rotavirus vaccines in 2006, rotavirus was the leading cause of severe gastroenteritis among US children <5 years of age. In the first 7 years of vaccine use, both recommended rotavirus vaccines (RotaTeq [RV5] and Rotarix [RV1]) have been shown to be highly effective in preventing outcomes of severe disease in US children in a variety of settings. In addition, substantial decreases in severe diarrheal disease in US children, exceeding the level expected based on vaccine coverage, as well as the extension of benefits to older age groups ineligible for vaccination have demonstrated both the direct and indirect impacts of vaccination in the USA.
No takes yet. Share an insight, caveat, or question.
Rha et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: